• Department of Outpatient, West China Hospital, Sichuan University, Chengdu 610041, China;
JIANG Guanyao, Email: hxl1963@yahoo.com.cn
Export PDF Favorites Scan Get Citation

Objective  To investigate safety of influenza A H1N1 vaccine vaccinations.
Methods  A total of 3 300 medical workers were vaccinated by batch of 200909012 influenza A H1N1 vaccine produced by Shanghai Biological Products Corporation Limited according to the principle of voluntary and concentration. The adverse reactions were observed within half an hour, three days and a week after vaccinations, respectively.
Results  The inoculators with local or systemic reaction reached 1.18% (39/3 300). There were 0.15% (5/3 300) of the inoculators with adverse reaction within half an hour; 0.70% (23/3 300) within 1 to 3 days after vaccination; and 0.33% (11/3 300) within 3 days to 1 week after vaccination. No severe adverse events were found.
Conclusion  Influenza A H1N1 vaccine vaccinations is an economic and effective way of influenza A H1N1 prevention with mild reactions.

Citation: HE Xiaoli,KANG Shuqiong,GONG Chengying,JIANG Guanyao. Safety Observation of Influenza A H1N1 Influenza Vaccine Vaccinations in 3300 Medical Workers. Chinese Journal of Evidence-Based Medicine, 2010, 10(4): 441-443. doi: 10.7507/1672-2531.20100424 Copy

  • Previous Article

    Evidence-Based Medicine in Medical Education Reform
  • Next Article

    Gankeshuangqing Capsule for Acute Upper Respiratory Infection: A Randomized Controlled Trial